Multiple myeloma (MM) is rare among patients with sickle cell syndromes (SC
S). We describe six Greek sickle cell patients aged 56 to 65 years: five ha
emoglobin S beta (+)thalassaemia (HbS beta (+)thal), one sickle cell anaemi
a (HbSS), who developed MM (three IgGK, one IgG lambda, one IgAK, and one I
gGK-IgAK (biclonal). Our HbS beta (+)thal cases, represent the first report
ed association of this entity with MM. Generalized bleeding diathesis, stro
ke, grand mal seizures, bone marrow necrosis and other clinical manifestati
ons due to hyperviscosity aggravated by sickle cell vasoocclusion were trea
ted by plasmaphereses and exchange blood transfusions. The increase of mean
survival in SCS patients due to the current medical facilities may have an
impact on the incidence of MM among them, if a pathogenetic link between t
he two conditions exists. All our patients carried a diagnosis of cholelith
iasis which may predispose to MM; two of them progressed from a monoclonal
gammopathy of undetermined significance (MGUS) to MM. Further studies are n
eeded in order to understand the relationship between SCS and MM.